Issue 26, 2013

Nanomolar cholera toxininhibitors based on symmetrical pentavalent ganglioside GM1os-sym-corannulenes

Abstract

Eight symmetric and pentavalent corannulene derivatives were functionalized with galactose and the ganglioside GM1-oligosaccharide (GM1os) via copper-catalyzed alkyne-azidecycloaddition (CuAAC) reactions. The compounds were evaluated for their ability to inhibit the binding of the pentavalent cholera toxin to its natural ligand, ganglioside GM1. In this assay, all ganglioside GM1os-sym-corannulenes proved to be highly potent nanomolar inhibitors of cholera toxin.

Graphical abstract: Nanomolar cholera toxin inhibitors based on symmetrical pentavalent ganglioside GM1os-sym-corannulenes

Supplementary files

Article information

Article type
Paper
Submitted
03 Mar 2013
Accepted
11 May 2013
First published
04 Jun 2013
This article is Open Access
Creative Commons BY license

Org. Biomol. Chem., 2013,11, 4333-4339

Nanomolar cholera toxininhibitors based on symmetrical pentavalent ganglioside GM1os-sym-corannulenes

M. Mattarella, J. Garcia-Hartjes, T. Wennekes, H. Zuilhof and J. S. Siegel, Org. Biomol. Chem., 2013, 11, 4333 DOI: 10.1039/C3OB40438B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements